InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Vincent Richard G, Chief Financial Officer. Officer active across 1 company, notably Oncternal Therapeutics, Inc.. In total, 8 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €16k. Activity tracked since 3 January 2022. The latest transaction was filed on 3 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Vincent Richard G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
8,868 shares@ US$0.496111.6% of flowCommon StockSEC:0001209191-24-000972:0
7,069 shares@ US$0.366.7% of flowCommon StockSEC:0001209191-23-041316:0
30,000 shares@ US$0.298723.4% of flowCommon StockSEC:0001209191-23-024263:0
Canonical exit: 12 Jul 2023 (T+90)
4,428 shares@ US$1.0212.2% of flowCommon StockSEC:0001209191-23-002028:0
43,125 shares0Common StockSEC:0001209191-22-043736:0
3 shares@ US$1.450.0% of flowCommon StockSEC:0001209191-22-021302:0
Canonical exit: 22 Jun 2022 (T+90)
5,000 shares@ US$1.8030.0% of flowCommon StockSEC:0001209191-22-005559:0
Canonical exit: 27 Apr 2022 (T+90)
29,867 shares0Common StockSEC:0001209191-22-001971:0
8 of 8 declarations
About Vincent Richard G
VINCENT RICHARD G is Directeur Financier and Chief Financial Officer at Oncternal Therapeutics, Inc. He has 8 filings in total, and across the 8 sampled recent filings, buys total 16115 EUR and sells total 0 EUR, with activity from 2022-01-05 to 2024-01-05. The most common transaction nature is Tax withholding.
